Effects of sodium butyrate on cell death induced by photodynamic therapy in U373-MG and D54-MG astrocytoma cell lines

Photochemistry and Photobiology

Volumn 85, Issue 5, 2009, Pages 1182-1188

  Flores Ancona, Roxana Magaly ^a   García Gómez, Fanny Yocelin ^a   Jiménez Betanzos, Ana María ^a   Solis Paredes, Mario ^a   Castro Leyva, Violeta ^a   Cruz Orea, Alfredo ^b   Arenas Huertero, Francisco ^a   Ramón Gallegos, Eva ^a  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; PRIMER DNA;

ARTICLE; ASTROCYTOMA; CELL DEATH; DRUG EFFECT; HUMAN; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHOTOCHEMOTHERAPY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ASTROCYTOMA; BASE SEQUENCE; BUTYRIC ACID; CELL DEATH; CELL LINE, TUMOR; DNA PRIMERS; HUMANS; PHOTOCHEMOTHERAPY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 69649095708     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1751-1097.2009.00561.x     Document Type: Article

References (40)

1. Instituto Nacional de Estadística, Geografía e Informática (2002) Estadística de mortalidad en México: muertes registradas en el 2001. Rev Salud Púb Mex 44, 565 581.
2. Dana-Farber Cancer Institute (2009) Brain tumors. Pediatric Low-Grade Astrocytoma (LGA) Program. Available at: http://www.danafarber.org/pat/ pediatric-care/pediatric-programs/brain-tumors/lga-program/program-leadership. html. Accessed on 25 February 2009.
3. Kleihues, P. H. Ohgaki (1999) Primary and secondary glioblastomas: From concept to clinical diagnosis. Neurooncology 1, 44 51.
4. Schmidt-Erfurth, U., H. Diddens, R. Birngruber T. Hasan (1997) Photodynamic targeting of human retinoblastoma cells using covalent low-density lipoprotein conjugates. Br. J. Cancer 75, 54 61.
5. Kessel, D. K. Woodburn (1993) Biodistribution of photosensitizing agents. Int. J. Biochem. 25, 1377 1383.
6. Oleinick, N. L., R. L. Morris I. Belichenko (2002) The role of apoptosis in response to photodynamic therapy: What, where, why and how. Photochem. Photobiol. Sci. 1, 1 21.
7. Kennedy, J. C., R. H. Pottier D. C. Pross (1990) Photodynamic therapy with endogenous protoporphyrin IX: Basic principles and present clinical experience. J. Photochem. Photobiol. 6, 143 148.
8. Ramón, G. E., R. I. DeLeón, G. L. Martínez Z. A. Pérez (1999) In vitro study of biosynthesis of protoporphyrin IX induced by δ-aminolevulinic acid in normal and cancerous cells of the human cervix. Arch. Med. Res. 30, 163 170.
9. Urnov, F. D. (2003) Chromatin remodeling as a guide to transcriptional regulatory networks in mammals. J. Cell. Biochem. 88, 684 694.
10. Gore, S. D. M. A. Carducci (2000) Modifying histones to care cancer: Clinical development of sodium phenylbutyrate and other histone deacetylase inhibitors. Expert OpInvest. Drugs 9, 2923 2934.
11. Marks, P. A., V. M. Richon R. A. Rifkind (2000) Histone deacetylase inhibitors: Inducers of differentiation or apoptosis of transformed cells. J. Natl Cancer Inst. 92, 1210 1216.
12. Joseph, J., G. Mudduluru, S. Antony, S. Vashistha, P. Ajitkumar K. Somasundaram (2004) Expression profiling of sodium butyrate (NaB)-treated cells: Identification of regulation of genes related to cytokine signaling and cancer metastasis by NaB. Oncogene 23, 6304 6315.
13. Widmer, J., K. S. Fassihi, S. C. Schlichter, K. S. Wheeler, B. E. Crute, N. King, N. Nutile-McMenemy, W. W. Noll, S. Daniel, J. Ha, K. H. Kim L. A. Witters (1996) Identification of a second human acetyl-CoA carboxylase gene. Biochem. J. 316, 915 922. (Pubitemid 26280088)
14. Wang, J., Y. Saunthararajah, R. L. Redner J. M. Liu (1999) Inhibitors of histone deacetylase relieve ETO-mediated repression and induce differentiation of AML1-ETO leukemia cells. Cancer Res. 59, 2766 2769.
15. Butler, L. M., D. B. Agus, H. I. Scher, B. Higgins, A. Rose, C. Cordon-Cardo, H. T. Thaler, R. A. Rifkind, P. A. Marks V. M. Richon (2000) Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo. Cancer Res. 60, 5165 5170.
16. Piomelli, S. A. (1973) Micromethod for free erythrocyte porphyrins: The FEP test. J. Lab. ClMed. 81, 932 940.
17. Rodríguez-Salvador, J., C. Armas-Pineda, F. Recillas-Targa, M. Pérezpeña-Diazconti, F. Chico-Ponce de León, G. Sosa-Sáinz, P. Lezama F. Arenas-Huertero (2005) Effect of sodium butyrate on the pro-matrixmetalloproteinase-9 and -2 differential secretion in pediatric tumors and cell lines. J. Exp. ClCancer Res. 24, 207 217.
18. Armas-Pineda, C., F. Arenas-Huertero, M. Pérezpeña- Diazconti, F. Chico-Ponce de León, G. Sosa-Sáinz, P. Lezama F. Recillas-Targa (2007) Expression of PCAF, p300 and Gcn5 and more highly acetylated histone H4 in pediatric tumors. J. Exp. ClCancer Res. 26, 269 276.
19. Johnstone, R. W. (2002) Histone-deacetylase inhibitors: Novel drugs for the treatment of cancer. Nat. Rev. Cancer 1, 287 299.
20. Van Lint, C., S. Emiliani E. Verdn (1996) The expression of small fraction of cellular gene is changed in response to histone hyperacetylation. Gene Expr. 5, 245 254.
21. Malik, Z., G. Kostenich, L. Roitman, B. Ehrenberg A. Orenstein (1995) Topical application of 5-aminolevulinic acid, DMSO and EDTA: Protoporphyrin IX accumulation in skin and tumours of mice. J. Photochem. Photobiol. B, Biol. 28, 213 218.
22. Biade, S., C. C. Stobbe, J. T. Boyd J. D. Chapman (2001) Chemical agents that promote chromatin compaction radiosensitize tumor cells. Int. J. Radiat. Biol. 77, 1033 1042.
23. Chinnaiyan, P., P. Vallabhaneni, E. Armstrong, A. M. Chinnaiyan, S. Huang P. M. Harari (2005) Modulation of radiation response by histone deacetylase inhibition. Int. J. Radiat. Oncol. Biol. Phys. 62, 223 229.
24. Munshi, A., J. F. Kurland T. Nishikawa (2005) Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity. ClCancer Res. 11, 4912 4922.
25. Kao, G. D., W. G. McKenna, M. G. Guenther, R. J. Muschel, M. A. Lazar T. J. Yen (2003) Histone deacetylase 4 interacts with 53BP1 to mediate the DNA damage response. J. Cell Biol. 160, 1017 1027.
26. Kim, I. A., J. H. Shin, I. H. Kim, J. H. Kim, J. S. Kim, H. G. Wu, E. K. Chie, S. W. Ha, C. I. Park G. D. Kao (2006) Histone deacetylase inhibitor-mediated radiosensitization of human cancer cells: Class differences and the potential influence of p53. ClCancer Res. 12, 940 949.
27. Zawacka-Pankau, J., N. Issaeva, S. Hossain, A. Pramanik, G. Selivanova A. J. Podhajska (2007) Protoporphyrin IX interacts with wild-type p53 protein in vitro and induces cell death of human colon cancer cells in a p53-dependent and -independent manner. J. Biol. Chem. 282, 2466 2472.
28. Dahle, J., H. B. Steen J. Moan (1999) The mode of cell death induced by photodynamic treatment depends on cell density. Photochem. Photobiol. 70, 363 367.
29. Ortel, B., N. Chen, J. Brissette, G. P. Dotto, E. Maytin T. Hasan (1998) Differentiation-specific increase in ALA-induced protoporphyrin IX accumulation in primary mouse keratinocytes. Br. J. Cancer 77, 1744 1751.
30. Gamaleia, N. F., E. D. Shishko, D. F. Gluzman L. M. Sklyarenko (2008) Sensitivity of normal and malignant human lymphocytes to 5-aminolevulinic acid-mediated photodynamic damage. Exp. Oncol. 30, 65 69.
31. Adcock, I. A., P. Ford, K. Ito P. J. Barnes (2006) Epigenetics and airway disease. Resp. Res. 7, 1 19.
32. Pajak, B., A. Orzechowski B. Gajkowska (2007) Molecular basis of sodium butyrate-dependent proapoptotic activity in cancer cells. Adv. Med. Sci. 52, 83 88.
33. Kamitani, H., S. Taniura, K. Watanabe, M. Sakamoto, T. Watanabe T. Eling (2002) Histone acetylation may suppress human glioma cell proliferation when p21 WAF/Cip1 and gelsolin are induced. Neurooncology 4, 95 101.
34. Kessel, D. Y. Luo (1998) Mitochondrial photodamage and PDT-induced apoptosis. J. Photochem. Photobiol. 42, 89 95.
35. Almeida, R. D., B. J. Manadas, A. P. Carvalho C. B. Duarte (2004) Intracellular signaling mechanisms in photodynamic therapy. Biochim. Biophys. Acta 1704, 59 86.
36. Neise, D., V. Graupner, B. F. Gillissen, P. T. Daniel, K. Schulze-Osthoff, R. U. Janicke F. Essmann (2008) Activation of the mitochondrial death pathway is commonly mediated by a preferential engagement of Bak. Oncogene 27, 1387 1396.
37. Hilf, R., J. J. Havens S. L. Gibson (1999) Effect of d-aminolevulinic acid on protoporphyrin IX accumulation in tumor cells transfected with plasmids containing porphobilinogen deaminase DNA. Photochem. Photobiol. 70, 334 340.
38. Wu, S. M., Q. G. Ren, M. O. Zhou, Q. Peng J. Y. Chen (2003) Protoporphyrin IX production and its photodynamic effects on glioma cells, neuroblastoma cells and normal cerebellar granule cells in vitro with 5-aminolevulinic acid and its hexylester. Cancer Lett. 200, 123 131.
39. Schwartz, D. I., Y. Gozlan, L. Green, T. Babushkina, D. J. Katcoff Z. Malik (2004) Differentiation-dependent photodynamic therapy regulated by porphobilinogen deamiaminase in B16 melanoma. Br. J. Cancer 90, 1833 1841.
40. Rense, C. K., S. Fickweiler, O. S. Wotfbeis R. Knuechel (2000) Cell type specific protoporphyrin IX metabolism in human bladder cancer in vitro. Photochem. Photobiol. 72, 226 233.